Xeljanz
Country: Եվրոպական Միություն
language: ֆիններեն
source: EMA (European Medicines Agency)
PAR
(PAR)
26-07-2013
documentation_request_body
documentation_request_send
documentation_request_send
active_ingredient:
Tofacitinib
MAH:
Pfizer Limited
INN:
tofacitinib
therapeutic_group:
immunosuppressantit
therapeutic_area:
Niveltulehdus, nivelreuma
therapeutic_indication:
Nivelreuman hoidossa.
authorization_status:
Refused
